SARS-CoV-2 High-throughput Screening
The outbreak of novel coronavirus, the first coronavirus to cause a global pandemic, has forced an acceleration in the development of antiviral drugs against the virus. Creative Biostructure is a professional contract research organization in the field of structural biology. With years of experience in structure-based preclinical drug discovery, we currently offer custom high-throughput antiviral drug screening services in the form of 96-well and 384-well plates. Our biochemical and cell-based high-throughput screening (HTS) technology enables the efficient screening of preclinical candidates for antiviral drug discovery of coronavirus from high-content compound libraries.